Huajian Medical Opens World’s First RWA Digitalization R&D Base in Nanjing

Huajian Medical, alongside its subsidiaries, signs a strategic $1.5 billion cooperation agreement with Transcenta Group to focus on tokenizing drug pipeline assets as Real-World Assets (RWAs).

Summary

Huajian Medical, in collaboration with its subsidiaries ETHK Inc and ETHK Holdings Limited, has signed a strategic cooperation agreement valued at $1.5 billion with Transcenta Group and Transcenta Oncology Inc. The partnership will explore tokenizing innovative drug pipeline assets as Real-World Assets (RWAs), advancing blockchain-based financial infrastructure in the healthcare sector.

Terms & Concepts
  • Real-World Asset (RWA) Tokenization: The process of converting real-world assets, like intellectual property or pharmaceutical assets, into digital tokens that can be transacted on a blockchain.
  • Tokenizing: The act of creating digital tokens that represent ownership or a share in a physical or intangible asset, such as property or intellectual property.